Co-Author
This page shows the publications co-authored by Jean Connors and Gregory Piazza.
Connection Strength
1.090
-
Update on Guidelines for the Management of Cancer-Associated Thrombosis. Oncologist. 2021 01; 26(1):e24-e40.
Score: 0.227
-
The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents. TH Open. 2020 Oct; 4(4):e288-e299.
Score: 0.225
-
Andexanet Alfa (Andexxa) Formulary Review. Crit Pathw Cardiol. 2019 06; 18(2):66-71.
Score: 0.204
-
Stability of alteplase for ultrasound-facilitated catheter-directed thrombolysis. Blood Adv. 2021 12 14; 5(23):5283-5289.
Score: 0.061
-
Use of novel antithrombotic agents for COVID-19: Systematic summary of ongoing randomized controlled trials. J Thromb Haemost. 2021 12; 19(12):3080-3089.
Score: 0.060
-
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021 04 20; 77(15):1903-1921.
Score: 0.058
-
Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative. Am J Med. 2020 05; 133 Suppl 1:1-27.
Score: 0.054
-
Running thin: implications of a heparin shortage. Lancet. 2020 02 15; 395(10223):534-536.
Score: 0.053
-
Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy. Am J Med. 2016 Nov; 129(11):1198-1204.
Score: 0.042
-
Regulatory, legislative, and policy updates with anticoagulant use. J Thromb Thrombolysis. 2015 Apr; 39(3):273-87.
Score: 0.038
-
Medication use evaluation: pharmacist rubric for performance improvement. Pharmacotherapy. 2014 Dec; 34 Suppl 1:5S-13S.
Score: 0.037
-
Dabigatran: a review of clinical and pharmacoeconomic evidence. Crit Pathw Cardiol. 2011 Sep; 10(3):117-27.
Score: 0.030
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.